<p>This is a summary of the European public assessment report (EPAR) for Duaklir Genuair. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Duaklir Genuair.</p><p>For practical information about using Duaklir Genuair, patients should read the package leaflet or contact their doctor or pharmacist.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Duaklir Genuair is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).</p></div>
Therapeutic Area (MeSH)
ATC Code
R03AL
ATC Item
N/A
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| aclidinium bromide | N/A | aclidinium bromide |
| formoterol fumarate dihydrate | N/A | formoterol fumarate dihydrate |
EMA Name
Duaklir Genuair
Medicine Name
Duaklir Genuair
Aliases
N/ANo risk management plan link.
